Skip to main content
BAX
NYSE Life Sciences

Baxter Surges 11% After Q2 Smash, Lifts 2026 Outlook on Turnaround Momentum

Tom Rudovsky · Reported by Benzinga
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$26.71
Mkt Cap
$13.795B
52W Low
$15.73
52W High
$30
52W Position info
70% above low
Off High info
11% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

BAX sits 70% above its 52-week low of $15.73 on elevated volume (1.8× avg).

Summary

Baxter delivered a clean Q2 beat with adjusted EPS of $0.54 vs. $0.37 consensus and revenue of $2.96B vs. $2.795B, driven by strength in advanced surgery and drug compounding. The company raised full-year 2026 adjusted EPS guidance to $1.95-$2.15 (from $1.85-$2.05) and sales guidance to $11.58B-$11.69B, both above consensus. Shares jumped 11% to $27.49, reflecting conviction in the turnaround narrative. CEO Hider noted improved execution but cautioned that the turnaround is still early. The Medical Products & Therapies segment led with 7% reported growth, while Healthcare Systems & Technologies grew 4%. This follows the segment realignment announced two weeks ago and the Q1 net loss, making the beat and raise a material positive signal. Watch for sustained margin expansion in H2 as higher-cost inventory rolls off.

At the time of this announcement, BAX was trading at $26.71 on NYSE in the Life Sciences sector, with a market capitalization of approximately $13.8B. The 52-week trading range was $15.73 to $30.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

BAX - Latest Insights

BAX
Oct 29, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.94
Real-time Price: $25.43 info
Change: +$2.49 (+11%) info
Market Cap: $13.135B info
BAX
Oct 29, 2026, 8:06 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $26.00
Real-time Price: $25.43 info
Change: -$0.570 (-2%) info
Market Cap: $13.135B info
BAX
Oct 29, 2026, 7:18 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.74
Real-time Price: $25.43 info
Change: -$1.31 (-5%) info
Market Cap: $13.135B info
BAX
Oct 29, 2026, 7:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $26.50
Real-time Price: $25.43 info
Change: -$1.07 (-4%) info
Market Cap: $13.135B info
BAX
Aug 19, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.20
Real-time Price: $25.43 info
Change: -$0.770 (-3%) info
Market Cap: $13.135B info